Market Cap (In KRW)
278.74 Billion
Revenue (In KRW)
196.34 Billion
Net Income (In KRW)
1.66 Billion
Avg. Volume
767.03 Thousand
- Currency
- KRW
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 6170.0-19500.0
- PE
- -
- EPS
- 0.0
- Beta Value
- 0.368
- ISIN
- KR7000520007
- CUSIP
- -
- CIK
- -
- Shares
- 21158942.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Kang Huh
- Employee Count
- -
- Website
- https://www.samil-pharm.com
- Ipo Date
- 2000-01-04
- Details
- Samil Pharmaceutical Co.,Ltd engages in the manufacture and sale of indispensable medicines in South Korea. It offers hepatic, gastrointestinal, vasodilator, antithrombotic, respiratory, skeletal muscle relaxants, circulatory, neurological, antibiotics, metabolic, antihistamines, immunosuppressive, hormone, anti-tumor, urinary, and ophthalmic drugs, as well as antipyretic, analgesic, and anti-inflammatory agents. The company also provides OTC products and sanitary aids. Samil Pharmaceutical Co.,Ltd was founded in 1947 and is headquartered in Seoul, South Korea.
More Stocks
-
100090SK oceanplant Co.,Ltd
100090
-
LFST
-
AURUMAurum PropTech Limited
AURUM
-
POWR
-
4284SOLXYZ Co., Ltd.
4284
-
8104
-
VTNRVertex Energy, Inc.
VTNR
-
605069